慢性支气管炎呼吸内科规范治疗的临床分析

Clinical analysis of standardized treatment of chronic bronchitis in the department of respiratory medicine

目的:观察呼吸内科规范化治疗慢性支气管炎患者的临床效果。方法:2018年1月-2019年12月收治慢性支气管炎患者100例,随机分为两组,各50例。对照组采用常规治疗,观察组采用常规治疗联合雾化吸入模式治疗,比较两组治疗效果。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:在常规治疗的基础上采用雾化吸入模式治疗慢性支气管炎患者,更有利于治疗,不良反应发生率低,相较于传统治疗模式更具安全性。

Objective:To observe the clinical effect of standardized treatment of respiratory medicine in patients with chronic bronchitis.Methods:From January 2018 to December 2019,100 patients with chronic bronchitis were selected,they were randomly divided into the two groups with 50 patients in each group.The control group was treated with routine treatment.The observation group was treated with routine treatment combined with atomization inhalation mode.The therapeutic effects of the two groups were compared.Results:The total effective rate of the observation group was higher than that of the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was significantly lower than that in the control group,the differences were statistically significant(P<0.05).Conclusion:On the basis of routine treatment,atomization inhalation mode is more beneficial to the treatment of chronic bronchitis,the incidence of adverse reactions is low,and it is more safe than the traditional treatment mode.